Change - Announcement of Cessation::CESSATION OF NON-EXECUTIVE DIRECTOR

Issuer & Securities

Issuer/ Manager
ASIAMEDIC LIMITED
Securities
ASIAMEDIC LIMITED - SG0505000059 - 505
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
17-Dec-2021 17:21:56
Status
New
Announcement Sub Title
CESSATION OF NON-EXECUTIVE DIRECTOR
Announcement Reference
SG211217OTHRK35O
Submitted By (Co./ Ind. Name)
Stanley Woo
Designation
Group Financial Controller
Description (Please provide a detailed description of the event in the box below)
Sponsor statement:
This announcement has been reviewed by the Company's Sponsor, Xandar Capital Pte Ltd, in compliance with Rule 226 of the Catalist Rules. It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "SGX-ST") and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms Pauline Sim (Registered Professional, Xandar Capital Pte Ltd) at 3 Shenton Way, #24-02 Shenton House, Singapore 068805. Telephone number: (65) 63194954.

Additional Details

Name Of Person
Joelle Lee Siew Hong
Age
50
Is effective date of cessation known?
Yes
If yes, please provide the date
31/12/2021
Detailed Reason (s) for cessation
Ms Lee is the Singapore Chief Executive Officer of Luye Medical Group Pte. Ltd. ("LMG"), the controlling shareholder of the Company. She will be resigning from LMG with effect from 27 December 2021. Consequently, she will also resign as a Director of the Company and its subsidiaries.

The Company's Sponsor, Xandar Capital Pte Ltd, has interviewed Ms Lee and is satisfied that, other than the reason as disclosed above, there are no material reasons for her cessation as Director.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
29/04/2021
Does the AC have a minimum of 3 members (taking into account this cessation)?
No
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
3
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
2
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Non-Executive Director
Audit and Risk Management Committee member
Nominating Committee member
Role and responsibilities
Please refer to Job Title section above.

Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
No
Shareholding interest in the listed issuer and its subsidiaries?
No
Past (for the last 5 years)
Please refer to the attachment.
Present
Please refer to the attachment.

Attachments

Directorships.pdf
Total size =166K